Literature DB >> 16365581

High-resolution computed tomography findings of lung cancer associated with idiopathic pulmonary fibrosis.

Kazuma Kishi1, Sakae Homma, Atsuko Kurosaki, Noriko Motoi, Kunihiko Yoshimura.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate high-resolution computed tomography (HRCT) findings of lung cancer associated with idiopathic pulmonary fibrosis (IPF).
METHODS: Thirty patients with lung cancer who had preceding IPF and were receiving regular follow-up between 1993 and 2002 were examined. Medical records, radiographs (including HRCT scans), and histologic slides were reviewed.
RESULTS: In 28 of the 30 patients, the most common HRCT pattern of lung cancer was a nodular lesion with soft tissue attenuation. Nodule margins were well defined in 23 lesions (82.1%), associated with lobulation in 24 (85.7%), or characterized by spiculation in 14 (50%). Air bronchogram was observed in 16 lesions (57.1%). All nodules were located in the peripheral area of fibrotic lesions. Squamous cell carcinoma and adenocarcinoma were the most frequent histologic types.
CONCLUSIONS: The typical HRCT findings of lung cancer were well-defined nodular lesions with lobulation in peripheral areas of the lung.

Entities:  

Mesh:

Year:  2006        PMID: 16365581     DOI: 10.1097/01.rct.0000188650.66527.d2

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  15 in total

Review 1.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 2.  High-resolution CT of complications of idiopathic fibrotic lung disease.

Authors:  C R Lloyd; S L F Walsh; D M Hansell
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

Review 3.  New perspectives on management of idiopathic pulmonary fibrosis.

Authors:  Silvia Puglisi; Sebastiano Emanuele Torrisi; Virginia Vindigni; Riccardo Giuliano; Stefano Palmucci; Massimiliano Mulè; Carlo Vancheri
Journal:  Ther Adv Chronic Dis       Date:  2016-02-01       Impact factor: 5.091

4.  Tonsillar metastasis of small cell lung cancer in a patient with idiopathic pulmonary fibrosis: a case report.

Authors:  Eo Jin Kim; So Ri Kim; Su Jin Gang; Seung Yong Park; Young Min Han; Yong Chul Lee
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

5.  Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.

Authors:  Eniko Barczi; Tamas Nagy; Livia Starobinski; Abigel Kolonics-Farkas; Noemi Eszes; Aniko Bohacs; Adam Domonkos Tarnoki; David Laszlo Tarnoki; Veronika Müller
Journal:  Thorac Cancer       Date:  2020-05-13       Impact factor: 3.500

6.  Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Authors:  AliReza JafariNezhad; Mohammad Hossein YektaKooshali
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

Review 7.  Idiopathic pulmonary fibrosis: the radiologist's role in making the diagnosis.

Authors:  Michael P Mohning; John Caleb Richards; Tristan J Huie
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

8.  Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study.

Authors:  Hongseok Yoo; Byeong-Ho Jeong; Myung Jin Chung; Kyung Soo Lee; O Jung Kwon; Man Pyo Chung
Journal:  BMC Pulm Med       Date:  2019-08-14       Impact factor: 3.317

Review 9.  Spectrum of early lung cancer presentation in low-dose screening CT: a pictorial review.

Authors:  Cristiano Rampinelli; Sonia Francesca Calloni; Marta Minotti; Massimo Bellomi
Journal:  Insights Imaging       Date:  2016-05-17

10.  Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathic pulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway.

Authors:  Yufeng Du; Xiaoyan Hao; Xuejun Liu
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.